Importantly, interrupting the TRIB3/AKT1 interaction by a modified α-helix peptide, Pep2–Ae, accelerated FOXO1 degradation, reduced SOX2 accumulation, and decreased the tumor-initiating capacity in MMTV-PyMT and PDX mice. The gene discussed is SOX2; the disease is neoplasm.